Biostatistics

Our service portfolio includes comprehensive expertise in pharmacokinetics, complementing our core capabilities in biostatistics and data management. Our biostatisticians also serve as our biometric programmers, enabling seamless integration of statistical analysis and programming workflows to deliver efficient, reproducible, and high-quality results.

The Biostatistics unit leverages R as the primary tool for statistical analysis and reporting. Every new project is developed as a standalone software environment with a fixed configuration that can be fully restored if necessary, ensuring reproducibility and robustness. We strictly adhere to good software development practices, which provides complete transparency throughout the software life cycle and enables thorough testing and validation.

Using R as the backbone of our statistical computing allows us access to the most advanced and up-to-date methodologies in statistical analysis, alongside state-of-the-art technologies for dynamic and comprehensive reporting. This technical foundation empowers us to meet complex and evolving analytical needs with precision and agility.

Our team brings extensive clinical research experience spanning all phases from Phase I to Phase IV, including registries. Our expertise covers the full spectrum of statistical activities, encompassing study design, data analysis, pharmacokinetic modeling, medical writing, and the publication of study results in high-impact scientific journals.

By combining advanced programming, rigorous statistical methodology, and deep clinical knowledge, we ensure that our clients receive integrated, scientifically sound, and regulatory-compliant solutions that support informed decision-making throughout the clinical development lifecycle.